AU Stock MarketDetailed Quotes

ACWOC Actinogen Medical Ltd

Watchlist
  • 0.008
  • 0.0000.00%
20min DelayMarket Closed Dec 19 11:21 AET
0Market Cap0.00P/E (Static)

Actinogen Medical Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
(FY)Jun 30, 2017
(FY)Jun 30, 2016
(FY)Jun 30, 2015
Operating cash flow (direct method)
Cash income from operating activities
3.20%4.79M
223.70%4.64M
-52.62%1.43M
-44.52%3.03M
68.52%5.46M
147.49%3.24M
-1,479.56%-6.82M
89.69%-431.81K
-54.84%-4.19M
-13,623.78%-2.7M
Income from government grants
3.20%4.79M
223.70%4.64M
-52.62%1.43M
-44.52%3.03M
68.52%5.46M
--3.24M
----
----
----
----
Other cash income from operating activities
----
----
----
----
----
----
-1,479.56%-6.82M
89.69%-431.81K
-54.84%-4.19M
---2.7M
Cash paid
-60.78%-22.01M
-24.67%-13.69M
-130.66%-10.98M
43.18%-4.76M
39.87%-8.38M
-1,090.10%-13.93M
-42.05%-1.17M
21.31%-824.22K
1.65%-1.05M
-72.09%-1.07M
Payments to suppliers for goods and services
-25.94%-5.71M
-52.33%-4.54M
-130.73%-2.98M
-12.14%-1.29M
11.50%-1.15M
-11.09%-1.3M
-42.05%-1.17M
21.31%-824.22K
1.65%-1.05M
-72.09%-1.07M
Other cash payments from operating activities
-78.05%-16.3M
-14.38%-9.15M
-130.64%-8M
51.99%-3.47M
42.79%-7.23M
---12.63M
----
----
----
----
Direct dividend received
----
----
----
----
----
----
-55.02%53.18K
19.87%118.23K
--98.64K
----
Direct interest paid
-18.27%-20.12K
-59.26%-17.01K
40.83%-10.68K
37.49%-18.05K
-261.61%-28.88K
30.29%-7.99K
-34.28%-11.46K
-32.59%-8.53K
---6.44K
----
Direct interest received
-20.63%291.02K
792.71%366.65K
51.61%41.07K
-71.20%27.09K
-54.02%94.06K
428.34%204.55K
3.14%38.72K
-63.97%37.54K
108.10%104.17K
254.51%50.06K
Operating cash flow
-94.88%-16.95M
8.60%-8.7M
-452.07%-9.52M
39.63%-1.72M
72.80%-2.86M
-32.70%-10.5M
-613.48%-7.91M
78.00%-1.11M
-35.47%-5.04M
-749.58%-3.72M
Investing cash flow
Cash flow from continuing investing activities
77.70%-8.16K
-1,146.14%-36.6K
52.54%-2.94K
72.81%-6.19K
-131.71%-22.76K
-96.52%71.77K
3.99%2.06M
149.36%1.98M
-14,212.68%-4.01M
707.30%28.45K
Net PPE purchase and sale
77.70%-8.16K
-1,146.14%-36.6K
52.54%-2.94K
72.81%-6.19K
---22.76K
----
73.27%-274
91.77%-1.03K
-143.80%-12.46K
707.30%28.45K
Net investment purchase and sale
----
----
----
----
----
----
3.95%2.06M
149.54%1.98M
---4M
----
Net other investing changes
----
----
----
----
----
--71.77K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
77.70%-8.16K
-1,146.14%-36.6K
52.54%-2.94K
72.81%-6.19K
-131.71%-22.76K
-96.52%71.77K
3.99%2.06M
149.36%1.98M
-14,212.68%-4.01M
707.30%28.45K
Financing cash flow
Cash flow from continuing financing activities
2,076.72%17.95M
-93.36%824.62K
22.83%12.42M
3,482.27%10.11M
-96.54%282.26K
-41.50%8.17M
5,070.31%13.96M
270K
748.56%12.37M
Net issuance payments of debt
----
----
----
----
-35.71%360K
--560K
----
----
----
----
Net common stock issuance
1,898.03%18.04M
-92.77%902.96K
22.52%12.49M
--10.2M
----
-43.24%7.92M
5,070.31%13.96M
--270K
----
748.56%12.37M
Net other financing activities
-17.05%-91.7K
-10.07%-78.34K
15.38%-71.17K
-8.18%-84.1K
75.49%-77.74K
---317.25K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
2,076.72%17.95M
-93.36%824.62K
22.83%12.42M
3,482.27%10.11M
-96.54%282.26K
-41.50%8.17M
5,070.31%13.96M
--270K
----
748.56%12.37M
Net cash flow
Beginning cash position
-48.32%8.46M
21.97%16.37M
166.28%13.42M
-34.00%5.04M
-22.84%7.64M
422.37%9.9M
151.95%1.89M
-92.33%751.98K
769.54%9.81M
902.24%1.13M
Current changes in cash
112.52%990.66K
-372.77%-7.91M
-65.40%2.9M
422.83%8.38M
-14.86%-2.6M
-127.87%-2.26M
609.70%8.11M
112.62%1.14M
-204.33%-9.05M
754.83%8.68M
Effect of exchange rate changes
----
----
--13.39K
----
----
----
----
----
----
----
Cash adjustments other than cash changes
----
-99.97%10
--35.27K
----
----
----
----
----
----
----
End cash Position
11.71%9.45M
-48.32%8.46M
21.97%16.37M
166.28%13.42M
-34.00%5.04M
-23.66%7.64M
428.01%10M
151.95%1.89M
-92.33%751.98K
769.54%9.81M
Free cash from
-94.15%-16.96M
8.25%-8.73M
-450.26%-9.52M
39.89%-1.73M
72.58%-2.88M
-32.70%-10.5M
-612.85%-7.91M
78.03%-1.11M
-35.51%-5.05M
-742.43%-3.73M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018(FY)Jun 30, 2017(FY)Jun 30, 2016(FY)Jun 30, 2015
Operating cash flow (direct method)
Cash income from operating activities 3.20%4.79M223.70%4.64M-52.62%1.43M-44.52%3.03M68.52%5.46M147.49%3.24M-1,479.56%-6.82M89.69%-431.81K-54.84%-4.19M-13,623.78%-2.7M
Income from government grants 3.20%4.79M223.70%4.64M-52.62%1.43M-44.52%3.03M68.52%5.46M--3.24M----------------
Other cash income from operating activities -------------------------1,479.56%-6.82M89.69%-431.81K-54.84%-4.19M---2.7M
Cash paid -60.78%-22.01M-24.67%-13.69M-130.66%-10.98M43.18%-4.76M39.87%-8.38M-1,090.10%-13.93M-42.05%-1.17M21.31%-824.22K1.65%-1.05M-72.09%-1.07M
Payments to suppliers for goods and services -25.94%-5.71M-52.33%-4.54M-130.73%-2.98M-12.14%-1.29M11.50%-1.15M-11.09%-1.3M-42.05%-1.17M21.31%-824.22K1.65%-1.05M-72.09%-1.07M
Other cash payments from operating activities -78.05%-16.3M-14.38%-9.15M-130.64%-8M51.99%-3.47M42.79%-7.23M---12.63M----------------
Direct dividend received -------------------------55.02%53.18K19.87%118.23K--98.64K----
Direct interest paid -18.27%-20.12K-59.26%-17.01K40.83%-10.68K37.49%-18.05K-261.61%-28.88K30.29%-7.99K-34.28%-11.46K-32.59%-8.53K---6.44K----
Direct interest received -20.63%291.02K792.71%366.65K51.61%41.07K-71.20%27.09K-54.02%94.06K428.34%204.55K3.14%38.72K-63.97%37.54K108.10%104.17K254.51%50.06K
Operating cash flow -94.88%-16.95M8.60%-8.7M-452.07%-9.52M39.63%-1.72M72.80%-2.86M-32.70%-10.5M-613.48%-7.91M78.00%-1.11M-35.47%-5.04M-749.58%-3.72M
Investing cash flow
Cash flow from continuing investing activities 77.70%-8.16K-1,146.14%-36.6K52.54%-2.94K72.81%-6.19K-131.71%-22.76K-96.52%71.77K3.99%2.06M149.36%1.98M-14,212.68%-4.01M707.30%28.45K
Net PPE purchase and sale 77.70%-8.16K-1,146.14%-36.6K52.54%-2.94K72.81%-6.19K---22.76K----73.27%-27491.77%-1.03K-143.80%-12.46K707.30%28.45K
Net investment purchase and sale ------------------------3.95%2.06M149.54%1.98M---4M----
Net other investing changes ----------------------71.77K----------------
Cash from discontinued investing activities
Investing cash flow 77.70%-8.16K-1,146.14%-36.6K52.54%-2.94K72.81%-6.19K-131.71%-22.76K-96.52%71.77K3.99%2.06M149.36%1.98M-14,212.68%-4.01M707.30%28.45K
Financing cash flow
Cash flow from continuing financing activities 2,076.72%17.95M-93.36%824.62K22.83%12.42M3,482.27%10.11M-96.54%282.26K-41.50%8.17M5,070.31%13.96M270K748.56%12.37M
Net issuance payments of debt -----------------35.71%360K--560K----------------
Net common stock issuance 1,898.03%18.04M-92.77%902.96K22.52%12.49M--10.2M-----43.24%7.92M5,070.31%13.96M--270K----748.56%12.37M
Net other financing activities -17.05%-91.7K-10.07%-78.34K15.38%-71.17K-8.18%-84.1K75.49%-77.74K---317.25K----------------
Cash from discontinued financing activities
Financing cash flow 2,076.72%17.95M-93.36%824.62K22.83%12.42M3,482.27%10.11M-96.54%282.26K-41.50%8.17M5,070.31%13.96M--270K----748.56%12.37M
Net cash flow
Beginning cash position -48.32%8.46M21.97%16.37M166.28%13.42M-34.00%5.04M-22.84%7.64M422.37%9.9M151.95%1.89M-92.33%751.98K769.54%9.81M902.24%1.13M
Current changes in cash 112.52%990.66K-372.77%-7.91M-65.40%2.9M422.83%8.38M-14.86%-2.6M-127.87%-2.26M609.70%8.11M112.62%1.14M-204.33%-9.05M754.83%8.68M
Effect of exchange rate changes ----------13.39K----------------------------
Cash adjustments other than cash changes -----99.97%10--35.27K----------------------------
End cash Position 11.71%9.45M-48.32%8.46M21.97%16.37M166.28%13.42M-34.00%5.04M-23.66%7.64M428.01%10M151.95%1.89M-92.33%751.98K769.54%9.81M
Free cash from -94.15%-16.96M8.25%-8.73M-450.26%-9.52M39.89%-1.73M72.58%-2.88M-32.70%-10.5M-612.85%-7.91M78.03%-1.11M-35.51%-5.05M-742.43%-3.73M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Heat List
AU
Overall
Symbol
Price
% Chg

No Data